Most synthetic cannabinoids are agonists from the cannabinoid receptors. They are already intended to be just like THC,[9] the all-natural cannabinoid Using the strongest binding affinity to the CB1 receptor, that is associated with the psychoactive outcomes or "substantial" of cannabis.[10] These artificial analogs typically have better binding af